Meghana Keshavan
ALS may soon be treatable with new drug combo dreamed up by a college student
Patients who took [an experimental medication for ALS] — initially dreamed up over beers and obsessive internet searching in a Brown ...
Structural discrimination: COVID-19 illuminates healthcare inequalities for blacks
The disparities have long been documented. Black people are more likely than white people to die from cancer. They are ...
In the age of DNA, sperm donors can no longer expect promises of anonymity to stand up
For generations, it was a basic tenet of donating sperm: Clinics could forever protect their clients’ identities. But, increasingly, donor ...
Inside the quest to find a place in modern medicine for magic mushrooms as a treatment for depression, other mental illnesses
Today, with a net worth of roughly $400 million accrued through various enterprises, [German financier Christian] Angermayer is one of ...
‘Wildly popular’ and unproven probiotics may interfere with some treatments
Probiotics are wildly popular. After all, the microbial cocktails are available over the counter and have been shown to be ...
Using single-cell sequencing to refine the search for disease culprits
[S]cientists, using a powerful technology called single-cell sequencing, have begun to peel apart the precise mechanisms of how individual cells ...
Seeking answers for sick babies through whole genome sequencing
When babies become intensely ill, it can be difficult to know what has gone wrong. But the answer, quite often, ...
Drug that ‘mutes’ defective genes that cause nerve disorders effective in trials
A crucial, late-stage clinical trial showed that the [nerve disorder drug patisiran] works—and that it’s safe. And now the biotech company ...
Asthma breakthrough? ‘Blockbuster’ Gleevec cancer drug shows promise in treating severe cases
A blockbuster cancer drug may have a surprising new use: It’s showing real promise in treating severe asthma. That may ...
Sequencing pioneer sets sights on $100 genome
Next-gen sequencing pioneer Illumina says it may soon usher in the era of the $100 genome — which could, in ...
Personalized cancer treatments struggling to overcome patient deaths, severe side effects
The idea is tantalizing: Reengineer a patient’s own immune cells to attack the cancer that’s killing her. Scientists have proven ...
Revolutionary CAR-T cancer therapy needs to nearly kill you to save you
[There is an] experimental therapy that...could rid [a patient's] body of cancer entirely. It’s called CAR-T therapy, and it works ...
FDA chief promotes new online tool for Precision Medicine Initiative
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. The Obama administration has ...
Breakthroughs in growing human tissue create excitement in biotech market
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. For decades, scientists and ...
Is Big Biotech starting to resemble Big Pharma?
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. As drug developers and ...
Candy-flavored ADHD drug has doctors concerned over potential for abuse
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Adzenys, as the chewable, ...
Nanotechnology could lead to revolution in drug development
Monoclonal antibody research skyrocketed in the 1980s. By the next decade, they hit the market and today, some of the ...
